These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6253394)

  • 21. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.
    Schmidt W; Festenstein H
    Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4-CD8+ T lymphocytes mediate AKR/gross murine leukemia virus nonresponsiveness in moderately aged AKR.H-2b:Fv-1b mice.
    Rich RF; Fujii T; Green WR
    J Immunol; 1992 May; 148(9):2961-7. PubMed ID: 1349325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of infectious murine leukemia virus and virus-related antigens in genetic crosses between AKR and the Fv-1 compatible strain C57L.
    Ikeda H; Rowe WP; Boyse EA; Stockert E; Sato H; Jacobs S
    J Exp Med; 1976 Jan; 143(1):32-46. PubMed ID: 172587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenicity of AKR endogenous leukemia viruses.
    Nowinski RC; Hays EF
    J Virol; 1978 Jul; 27(1):13-8. PubMed ID: 211248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H-2-specific antibodies induced by injection of syngeneic leukemia cells.
    Schmidt W
    Immunogenetics; 1987; 25(4):215-21. PubMed ID: 3570375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF; Cook WJ; Green WR
    Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonresponsiveness of AKR.H-2b congenic mice for anti-AKR/Gross MuLV CTL responses: involvement of inhibitory cells as defined by adoptive transfer experiments.
    Rich RF; Green WR
    Cell Immunol; 1995 Jan; 160(1):139-51. PubMed ID: 7842479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
    Barnes RD; Tuffrey M; Holliday J; Hilgers JH; Souissi T
    Br J Cancer; 1976 Jul; 34(1):28-38. PubMed ID: 182191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in RNA tumor virus expression in H-2 congenic leukemia cell lines.
    Wolfe JH; Blank KJ; Pincus T
    Immunogenetics; 1981; 12(1-2):187-90. PubMed ID: 7203555
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection.
    Fish DC; Gilden RV; Bare RM; Trimmer RM; Huebner RJ
    J Natl Cancer Inst; 1979 Apr; 62(4):943-5. PubMed ID: 219284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restricted expression of ecotropic virus by thymocytes of leukemia-resistant (AKR X NZB)F1 mice.
    Datta SK; Schwartz RS
    J Exp Med; 1978 Jul; 148(1):329-34. PubMed ID: 209123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fv-1 regulation of lymphoma development and of thymic ecotropic and xenotropic MuLV expression in mice of the AKR/J x RF/J cross.
    Mayer A; Duran-Reynals ML; Lilly F
    Cell; 1978 Oct; 15(2):429-35. PubMed ID: 214239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses.
    Yoshiki T; Mellors RC; Hardy WD
    Proc Natl Acad Sci U S A; 1973 Jun; 70(6):1878-82. PubMed ID: 4352660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor.
    Gorzynski TJ; Lennon VA; Nathanson RM; David CS
    J Immunol; 1985 Apr; 134(4):2079-83. PubMed ID: 3919088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice.
    Kawashima K; Ikeda H; Hartley JW; Stockert E; Rowe WP; Old LJ
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4680-4. PubMed ID: 188051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations of in vivo growth of CTL-susceptible and -resistant variant tumor cell lines in CTL-responder AKR.H-2b:Fv-1b and -nonresponder AKR.H-2b mice.
    Azuma H; Wegmann KW; Green WR
    Cell Immunol; 1988 Oct; 116(1):123-34. PubMed ID: 3262427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses.
    Cloyd MW; Hartley JW; Rowe WP
    J Exp Med; 1980 Mar; 151(3):542-52. PubMed ID: 6244357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.